Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart

AIMS: To evaluate the pharmacokinetics and pharmacodynamics of faster‐acting insulin aspart and insulin aspart in a randomized, single‐centre, double‐blind study. METHODS: Fifty‐two patients with type 1 diabetes (mean age 40.3 years) received faster‐acting insulin aspart, insulin aspart, or another...

Descripción completa

Detalles Bibliográficos
Autores principales: Heise, T., Hövelmann, U., Brøndsted, L., Adrian, C. L., Nosek, L., Haahr, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054830/
https://www.ncbi.nlm.nih.gov/pubmed/25846340
http://dx.doi.org/10.1111/dom.12468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054830/
https://www.ncbi.nlm.nih.gov/pubmed/25846340
http://dx.doi.org/10.1111/dom.12468

Ejemplares similares